Insider · CIK 0002071953
David Baxley Spetzler
presidentofficer
Files at CAI (Caris Life Sciences, Inc.). First filing Sep 4, 2026, latest Sep 4, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $15M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CAI: Caris Life Sciences, Inc.
CAIOct 9, 2026 · close 29.70
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Caris Life Sciences, Inc. | $15M 597,212 shares | -39% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | CAI Caris Life Sciences, Inc. | MOption exercise Common Stock | +1,000,000 | $2.44 | $2.4M | 1,530,083 | 38 d ago |
| Sep 3, 2026 | CAI Caris Life Sciences, Inc. | SOpen-market sale Common Stock | -393,100 | $24.76 | $9.7M | 1,136,983 | 38 d ago |
| Sep 3, 2026 | CAI Caris Life Sciences, Inc. | SOpen-market sale Common Stock | -84,900 | $25.32 | $2.1M | 1,052,083 | 38 d ago |
| Sep 4, 2026 | CAI Caris Life Sciences, Inc. | MOption exercise Common Stock | +250,000 | $2.44 | $610k | 1,302,083 | 38 d ago |
| Sep 4, 2026 | CAI Caris Life Sciences, Inc. | SOpen-market sale Common Stock | -119,212 | $24.76 | $3.0M | 1,182,871 | 38 d ago |
| Sep 3, 2026 | CAI Caris Life Sciences, Inc. | MOption exercise Stock Optionderivative | -1,000,000 | $0.00 | $0 | 250,000 | 38 d ago |
| Sep 4, 2026 | CAI Caris Life Sciences, Inc. | MOption exercise Stock Optionderivative | -250,000 | $0.00 | $0 | 0 | 38 d ago |
| Mar 3, 2025 | CAI Caris Life Sciences, Inc. | DDisposition to issuer Common Stock | -700,509 | $18.60 | $13M | 351,240 | Jun 23, 2025 |
| Jun 18, 2025 | CAI Caris Life Sciences, Inc. | AGrant or award Common Stock | +132,428 | $0.00 | $0 | 483,668 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | MOption exercise Common Stock | +75,000 | $2.44 | $183k | 558,668 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | FTax withholding Common Stock | -34,782 | $27.25 | $948k | 523,886 | Jun 23, 2025 |
| Mar 3, 2025 | CAI Caris Life Sciences, Inc. | AGrant or award Stock Optionderivative | +750,000 | $0.00 | $0 | 750,000 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | MOption exercise Stock Optionderivative | -75,000 | $0.00 | $0 | 0 | Jun 23, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.